Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Clinical Practice Review

2.50
Hdl Handle:
http://hdl.handle.net/10755/602521
Category:
Full-text
Format:
Text-based Document
Type:
Poster
Title:
Pre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Clinical Practice Review
Author(s):
Ng, Yeow Chye; Gaines, Rebecca M.; Gaines, Rebecca M.
Lead Author STTI Affiliation:
Beta Phi
Author Details:
Yeow Chye Ng, RN, FNP-BC, NP-C, NRCME, AAHIVE, ngy@uah.edu; Rebecca M. Gaines, RN, FNP-BC
Abstract:
Session presented on Saturday, November 7, 2015 and Sunday, November 8, 2015: Background: Primary care providers should possess current, evidenced-based knowledge in order to provide competent and compassionate patient care. According to research evidence, there is a wide variance with respect to HIV/AIDS knowledge, attitudes, and behaviors among healthcare providers. Unfortunately, knowledge deficits and preconceived ideas may create major barriers for HIV-positive patients seeking care. Due to the recent availability of PrEP medication guidelines, nurse practitioners should expect more patients to present to clinical sites, requesting information on HIV prevention and treatment modalities measures. In fact, a recent nurse practitioner conference survey showed that 85% of providers were unaware of the 2014 Clinical Practice Guidelines for the PrEP program and agreed that the new guidelines would present several challenges due to lack of standardization. Methods: A review of the literature was conducted on PrEP articles published between 2011 and 2014 from four major organizations: Centers for Disease Control and Prevention (CDC), United States Food and Drug Administration (FDA), New York State Department of Health, AIDS Institute (NYSDOH), and the United States Public Health Service (USPHS). Findings: In 2011, CDC released an interim guidance titled PrEP for Men who have Sex with Men (MSM). July 2012, FDA approved two combination drugs (TDF/FTC) for PrEP treatment. August 2012, CDC released another interim guidance on PrEP program for heterosexuals. June 2013, CDC further expands the guidance on PrEP program for Injecting Drug User (IDU) population. January 2014, the NYSDOH released an online guidance for PrEP program. May 2014, USPHS officially published the first clinical practice guideline for PrEP program. Recommendations from these organizations were synthesized, based on appropriate clinical practice guidelines for advanced practice nurses. Summary/Implications for Practice: Primary prevention is unmistakably the solution to reducing the prevalence of new HIV cases. After many years of research, the PrEP program was FDA-approved in 2012; therefore, it is the responsibility of advanced practice nurses to know current, evidenced-based prevention and treatment recommendations as they take their place as a vital member of the healthcare team.
Keywords:
Pre-Exposure Prophylaxis (PrEP); Clinical practice guidelines; HIV primary prevention
Repository Posting Date:
21-Mar-2016
Date of Publication:
21-Mar-2016
Other Identifiers:
CONV15CL1.11
Conference Date:
2015
Conference Name:
43rd Biennial Convention
Conference Host:
Sigma Theta Tau International, the Honor Society of Nursing
Conference Location:
Las Vegas, Nevada, USA
Description:
43rd Biennial Convention 2015 Theme: Serve Locally, Transform Regionally, Lead Globally.`

Full metadata record

DC FieldValue Language
dc.language.isoen_USen
dc.type.categoryFull-texten
dc.formatText-based Documenten
dc.typePosteren
dc.titlePre-Exposure Prophylaxis (PrEP) for HIV Prevention: A Clinical Practice Reviewen
dc.contributor.authorNg, Yeow Chyeen
dc.contributor.authorGaines, Rebecca M.en
dc.contributor.authorGaines, Rebecca M.en
dc.contributor.departmentBeta Phien
dc.author.detailsYeow Chye Ng, RN, FNP-BC, NP-C, NRCME, AAHIVE, ngy@uah.edu; Rebecca M. Gaines, RN, FNP-BCen
dc.identifier.urihttp://hdl.handle.net/10755/602521en
dc.description.abstractSession presented on Saturday, November 7, 2015 and Sunday, November 8, 2015: Background: Primary care providers should possess current, evidenced-based knowledge in order to provide competent and compassionate patient care. According to research evidence, there is a wide variance with respect to HIV/AIDS knowledge, attitudes, and behaviors among healthcare providers. Unfortunately, knowledge deficits and preconceived ideas may create major barriers for HIV-positive patients seeking care. Due to the recent availability of PrEP medication guidelines, nurse practitioners should expect more patients to present to clinical sites, requesting information on HIV prevention and treatment modalities measures. In fact, a recent nurse practitioner conference survey showed that 85% of providers were unaware of the 2014 Clinical Practice Guidelines for the PrEP program and agreed that the new guidelines would present several challenges due to lack of standardization. Methods: A review of the literature was conducted on PrEP articles published between 2011 and 2014 from four major organizations: Centers for Disease Control and Prevention (CDC), United States Food and Drug Administration (FDA), New York State Department of Health, AIDS Institute (NYSDOH), and the United States Public Health Service (USPHS). Findings: In 2011, CDC released an interim guidance titled PrEP for Men who have Sex with Men (MSM). July 2012, FDA approved two combination drugs (TDF/FTC) for PrEP treatment. August 2012, CDC released another interim guidance on PrEP program for heterosexuals. June 2013, CDC further expands the guidance on PrEP program for Injecting Drug User (IDU) population. January 2014, the NYSDOH released an online guidance for PrEP program. May 2014, USPHS officially published the first clinical practice guideline for PrEP program. Recommendations from these organizations were synthesized, based on appropriate clinical practice guidelines for advanced practice nurses. Summary/Implications for Practice: Primary prevention is unmistakably the solution to reducing the prevalence of new HIV cases. After many years of research, the PrEP program was FDA-approved in 2012; therefore, it is the responsibility of advanced practice nurses to know current, evidenced-based prevention and treatment recommendations as they take their place as a vital member of the healthcare team.en
dc.subjectPre-Exposure Prophylaxis (PrEP)en
dc.subjectClinical practice guidelinesen
dc.subjectHIV primary preventionen
dc.date.available2016-03-21T16:30:51Zen
dc.date.issued2016-03-21en
dc.date.accessioned2016-03-21T16:30:51Zen
dc.conference.date2015en
dc.conference.name43rd Biennial Conventionen
dc.conference.hostSigma Theta Tau International, the Honor Society of Nursingen
dc.conference.locationLas Vegas, Nevada, USAen
dc.description43rd Biennial Convention 2015 Theme: Serve Locally, Transform Regionally, Lead Globally.`en
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.